FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989036742> ?p ?o ?g. }

• W1989036742 endingPage "224" @default.
• W1989036742 startingPage "218" @default.
• W1989036742 abstract "Patients with heart failure (HF) have reduced exercise capacity. The beneficial effect of beta-blocker on prognosis is not matched by an impact on exercise capacity and quality of life. We performed a randomised open blinded endpoint study to assess the effect of heart rate reduction with carvedilol, ivabradine, and their combination on exercise capacity in HF patients receiving maximal dose of ACE inhibitor.After a run-in phase patients were randomly allocated to 3 groups: carvedilol up to 25mg bid (n=38); ivabradine up to 7.5mg bid (n=41); and carvedilol/ivabradine up to 12.5/7.5mg bid (n=42). The maximal dose of study treatment was more frequently tolerated in patients receiving ivabradine (36/41) than in those receiving carvedilol (18/38) or combination therapy (32/42) (P<0.01 ivabradine versus carvedilol). Heart rate was reduced in all three groups, but to a greater extent by the combination. The distance walked on the 6-min walking test and the exercise time on MVO(2) test significantly improved in the ivabradine and combination groups (both P<0.01 versus baseline), as did peak VO(2) and VAT (P<0.01 for ivabradine and P<0.03 for combination versus carvedilol, respectively). No changes in these parameters were found with carvedilol. The patients receiving ivabradine or the combination had better quality of life (P<0.01 versus baseline for ivabradine and P<0.02 for combination), versus no change with carvedilol.Ivabradine alone or in combination with carvedilol is more effective than carvedilol alone at improving exercise tolerance and quality of life in HF patients." @default.
• W1989036742 created "2016-06-24" @default.
• W1989036742 creator A5011612086 @default.
• W1989036742 creator A5021125403 @default.
• W1989036742 creator A5053557780 @default.
• W1989036742 creator A5059131786 @default.
• W1989036742 creator A5064706121 @default.
• W1989036742 creator A5064940682 @default.
• W1989036742 creator A5078111994 @default.
• W1989036742 creator A5087924459 @default.
• W1989036742 creator A5087977641 @default.
• W1989036742 date "2011-09-01" @default.
• W1989036742 modified "2023-10-17" @default.
• W1989036742 title "Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial)" @default.
• W1989036742 cites W1654241318 @default.
• W1989036742 cites W176571599 @default.
• W1989036742 cites W1985431801 @default.
• W1989036742 cites W1987894901 @default.
• W1989036742 cites W1991598670 @default.
• W1989036742 cites W2010396034 @default.
• W1989036742 cites W2021453721 @default.
• W1989036742 cites W2038065774 @default.
• W1989036742 cites W2040223416 @default.
• W1989036742 cites W2047445883 @default.
• W1989036742 cites W2056665255 @default.
• W1989036742 cites W2085979656 @default.
• W1989036742 cites W2094752159 @default.
• W1989036742 cites W2095339761 @default.
• W1989036742 cites W2102948895 @default.
• W1989036742 cites W2106448983 @default.
• W1989036742 cites W2110205270 @default.
• W1989036742 cites W2113492921 @default.
• W1989036742 cites W2122984949 @default.
• W1989036742 cites W2125268034 @default.
• W1989036742 cites W2126495538 @default.
• W1989036742 cites W2129134633 @default.
• W1989036742 cites W2136061470 @default.
• W1989036742 cites W2136642260 @default.
• W1989036742 cites W2137534212 @default.
• W1989036742 cites W2139010126 @default.
• W1989036742 cites W2147260094 @default.
• W1989036742 cites W2154143064 @default.
• W1989036742 cites W2157184686 @default.
• W1989036742 cites W2163823318 @default.
• W1989036742 cites W2164145340 @default.
• W1989036742 cites W2165141146 @default.
• W1989036742 cites W2168010680 @default.
• W1989036742 cites W2171082699 @default.
• W1989036742 cites W2181350280 @default.
• W1989036742 cites W2990123797 @default.
• W1989036742 cites W4245666729 @default.
• W1989036742 doi "https://doi.org/10.1016/j.ijcard.2011.06.098" @default.
• W1989036742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21764469" @default.
• W1989036742 hasPublicationYear "2011" @default.
• W1989036742 type Work @default.
• W1989036742 sameAs 1989036742 @default.
• W1989036742 citedByCount "105" @default.
• W1989036742 countsByYear W19890367422012 @default.
• W1989036742 countsByYear W19890367422013 @default.
• W1989036742 countsByYear W19890367422014 @default.
• W1989036742 countsByYear W19890367422015 @default.
• W1989036742 countsByYear W19890367422016 @default.
• W1989036742 countsByYear W19890367422017 @default.
• W1989036742 countsByYear W19890367422018 @default.
• W1989036742 countsByYear W19890367422019 @default.
• W1989036742 countsByYear W19890367422020 @default.
• W1989036742 countsByYear W19890367422021 @default.
• W1989036742 countsByYear W19890367422022 @default.
• W1989036742 countsByYear W19890367422023 @default.
• W1989036742 crossrefType "journal-article" @default.
• W1989036742 hasAuthorship W1989036742A5011612086 @default.
• W1989036742 hasAuthorship W1989036742A5021125403 @default.
• W1989036742 hasAuthorship W1989036742A5053557780 @default.
• W1989036742 hasAuthorship W1989036742A5059131786 @default.
• W1989036742 hasAuthorship W1989036742A5064706121 @default.
• W1989036742 hasAuthorship W1989036742A5064940682 @default.
• W1989036742 hasAuthorship W1989036742A5078111994 @default.
• W1989036742 hasAuthorship W1989036742A5087924459 @default.
• W1989036742 hasAuthorship W1989036742A5087977641 @default.
• W1989036742 hasConcept C126322002 @default.
• W1989036742 hasConcept C164705383 @default.
• W1989036742 hasConcept C2777953023 @default.
• W1989036742 hasConcept C2778198053 @default.
• W1989036742 hasConcept C2779167562 @default.
• W1989036742 hasConcept C2780591200 @default.
• W1989036742 hasConcept C42219234 @default.
• W1989036742 hasConcept C71924100 @default.
• W1989036742 hasConcept C84393581 @default.
• W1989036742 hasConceptScore W1989036742C126322002 @default.
• W1989036742 hasConceptScore W1989036742C164705383 @default.
• W1989036742 hasConceptScore W1989036742C2777953023 @default.
• W1989036742 hasConceptScore W1989036742C2778198053 @default.
• W1989036742 hasConceptScore W1989036742C2779167562 @default.
• W1989036742 hasConceptScore W1989036742C2780591200 @default.
• W1989036742 hasConceptScore W1989036742C42219234 @default.
• W1989036742 hasConceptScore W1989036742C71924100 @default.
• W1989036742 hasConceptScore W1989036742C84393581 @default.
• W1989036742 hasIssue "2" @default.

• next